The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AGILE THERAPEUTICS INC | COM | 00847L100 | 12,385 | 1,774,319 | SH | SOLE | 1,774,319 | 0 | 0 | ||
AMERICAN CAP SR FLOATING LTD | COM | 02504D108 | 180 | 16,339 | SH | SOLE | 16,339 | 0 | 0 | ||
BERKSHIRE HATHAWAY INC DEL | CL B NEW | 084670702 | 1,292 | 8,945 | SH | SOLE | 8,945 | 0 | 0 | ||
CIDARA THERAPEUTICS INC | COM | 171757107 | 211 | 18,425 | SH | SOLE | 18,425 | 0 | 0 | ||
CM FIN INC | COM | 12574Q103 | 149 | 16,409 | SH | SOLE | 16,409 | 0 | 0 | ||
CSW INDUSTRIALS INC | COM | 126402106 | 364 | 11,253 | SH | SOLE | 11,253 | 0 | 0 | ||
DOVER CORP | COM | 260003108 | 237 | 3,224 | SH | SOLE | 3,224 | 0 | 0 | ||
GARRISON CAP INC | COM | 366554103 | 162 | 15,995 | SH | SOLE | 15,995 | 0 | 0 | ||
MADRIGAL PHARMACEUTICALS INC | COM | 558868105 | 6,425 | 506,738 | SH | SOLE | 506,738 | 0 | 0 | ||
MADRIGAL PHARMACEUTICALS INC | COM | 558868105 | 26 | 2,057 | SH | Call | SOLE | 2,057 | 0 | 0 | |
MEDLEY CAP CORP | COM | 58503F106 | 209 | 27,357 | SH | SOLE | 27,357 | 0 | 0 | ||
PARATEK PHARMACEUTICALS INC | COM | 699374302 | 246 | 18,909 | SH | SOLE | 18,909 | 0 | 0 | ||
STELLUS CAP INVT CORP | COM | 858568108 | 262 | 24,103 | SH | SOLE | 24,103 | 0 | 0 | ||
STRONGBRIDGE BIOPHARMA PLC | SHS USD | G85347105 | 184 | 35,245 | SH | SOLE | 35,245 | 0 | 0 |